Home
About
About Anagenics
Board of Directors
Divisions
Our Divisions
Beauty
Brands
évolis®
Uspa
Investors
Investor Centre
ASX Announcements
2024
2023
2022
2021
2020
2019
Financial Information & Reports
Share Registry Information
Analyst Coverage
Share Information
Anagenics in the media
Newsletter Archive
Corporate Governance
Corporate Governance
Board Charter
Code of Conduct
Policies
Audit Committee Charter
Nomination and Remuneration Committee Charter
Performance Evaluation Process
Corporate Code of Conduct
Environmental, Social and Governance Statement
✕
2021
Home
2021
April 1, 2021
Published by
Dominic Burg
on
April 1, 2021
Categories
Change of Director’s Interest Notice – Gordon
April 1, 2021
Published by
Dominic Burg
on
April 1, 2021
Categories
CDYOA Top20 and Distribution List
April 1, 2021
Published by
Dominic Burg
on
April 1, 2021
Categories
Appendix 2A
April 1, 2021
Published by
Dominic Burg
on
April 1, 2021
Categories
Supplementary Prospectus
April 1, 2021
Published by
Dominic Burg
on
April 1, 2021
Categories
Proposed issue of Securities – CDY
April 1, 2021
Published by
Dominic Burg
on
April 1, 2021
Categories
Rights Issue Closed with Strong Demand
March 25, 2021
Published by
Dominic Burg
on
March 25, 2021
Categories
Cellmid receives R&D tax credit
March 15, 2021
Published by
Dominic Burg
on
March 15, 2021
Categories
Dispatch of Rights Issue Documentation Completed
March 10, 2021
Published by
Dominic Burg
on
March 10, 2021
Categories
Investor Presentation
Prev page
1
2
3
4
5
6
7
Next page
